Navigation Links
Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference
Date:1/13/2014

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today provided an update on the anticipated milestones for its product development programs in 2014.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"Halozyme is poised for a pivotal year in 2014," stated Dr. Helen Torley, President and Chief Executive Officer.  "With multiple collaboration products advancing to commercialization stage, our focus is now on advancing and unlocking the value of our three proprietary products, which are potentially game-changing for the company. There are a number of key development and commercialization events over the next twelve months that can be used to measure our progress."

"For PEGPH20, these include completion of enrollment of the Phase 2 pancreatic cancer study (Study 202) and initiation of a study to evaluate PEGPH20 in an additional tumor setting. With respect to our diabetes program, we plan to communicate results from the CONSISTENT 1 study of Hylenex® as a pre-treatment in patients with diabetes using insulin pumps in the first quarter of 2014. In support of maximizing the commercial potential of Hylenex as a pre-treatment in patients with diabetes using insulin pumps, in the coming weeks, we will be seeking input from the FDA regarding the path for a labeling update to include key efficacy and safety data prior to initiating promotion for this use. For HTI-501, we look forward to communicating top-line results from our cellulite trial also in the first quarter of 2014."

Proprietary Products

PEGPH20

  • Complete enrollment in the on-going Phase 2 multicenter, randomized clinical trial (Study 202) evaluating P
    '/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Secures Additional $20 Million Term Loan
2. Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics
3. Halozyme Therapeutics Announces Executive Transitions
4. Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference
5. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
6. Halozyme to Host Third Quarter 2013 Financial Results Conference Call
7. SWOG Initiates Randomized Phase 2 Clinical Trial of Halozymes PEGPH20 in Combination with modified FOLFIRINOX for Advanced Pancreatic Cancer
8. Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 2013
9. Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche
10. Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
11. Halozyme to Present New Data on PEGPH20 in Pancreatic Cancer at European Cancer Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that Steven ... and David Haen , Vice President of ... corporate overview at two significant investment conferences in ... industries: the FBR & Co. Second Annual Health ...
(Date:9/1/2015)... 1, 2015 Pressure BioSciences, Inc. (OTCQB: ... the development and sale of broadly enabling, pressure ... worldwide life sciences industry, today announced the publication ... Company,s PCT Platform could play a significant role ... role is based on PCT,s unique ability to ...
(Date:9/1/2015)... , September 1, 2015 ... company, today announces that it has appointed Hilde ... Non-Executive Directors to its Board of Directors, effective immediately. ... years of experience in pharma and biotech and is ... a Sanofi company. Previously her role was Vice President ...
Breaking Medicine Technology:CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5BerGenBio Appoints Non-Executive Directors 2
... Pricing of $500 Million of Senior Notes in Connection with... -- ARDEE, Ireland, Sept. 24 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... Misonix, Inc. (Nasdaq: MSON ), a ... technology, which worldwide is used for acute health conditions, ... ended June 30, 2010 financial results on Tuesday, September ... Officer and Richard Zaremba, Senior VP and Chief Financial ...
Cached Medicine Technology:Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 8Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern 2
(Date:9/1/2015)... ... ... The FSH Society , the Massachusetts-based charity that has transformed the ... beneficiary of a collection of fundraising events this fall. From Boston to Los Angeles, ... and further FSHD research. , The list of 2015 fall events include: ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed Szczesny ... October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, and ...
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... ... to date, more than 1,500 investor-families have received permanent green cards (I-829 petition ... projects. , The I-829 petition is the final step of the EB-5 visa ...
(Date:9/1/2015)... Aventura, Florida (PRWEB) , ... September 01, 2015 ... ... across language barriers and international borders seldom arise at the most convenient time ... which is always ready to help. , Universal Translation Services has ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... it has established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. ... This rapidly-growing alliance is dedicated to the provision of quality addiction treatment ...
Breaking Medicine News(10 mins):Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:MAP Health Management Launches the MAP Recovery Network 2
... from International Agency for Cancer Research scientists (IACR) have ... incidence of lung cancer. ,The study was conducted ... individuals from Poland, Slovakia, Czech Republic, Romania, Russia and ... the diet. The study has found that eating cabbage ...
... Bilaspur, M. P. in its specialty hospital has a ... Bangalore based company called Televital. Now the Bilaspur Hospital ... and Nagpur. The Telemedicine network is implemented on Optical ... Indian Railway has had an optical fibre network in ...
... childbearing, and a small number of carefully planned// pregnancies, ... disappointment and grief when they occur. A study has ... whether abortion increased a woman’s chance of suffering from ... women who aborted or delivered an unwanted pregnancy reveal ...
... smoking has been widely recognized. Passive smoking has been ... with an increased risk of coronary heart disease eventually ... marker of in vivo oxidation injury, have been shown ... for passive smoking are lacking. , ,Recently, researchers ...
... starts three-year lifestyle campaign to fight osteoporosis Exercise can help ... report explains. , ,'One of the best ways to ... Helmut Minne, IOF Board member and author of Move it ... strong bones, prevent falls and fractures and speed rehabilitation. ...
... to create strange type of histories all the time. Now ... produce a baby boy after one of them was left ... an environmental assistant from Woolwich in southeast London was declared ... egg) and their eldest sister carried the fetus in ...
Cached Medicine News:Health News:Cabbage And Genes May Protect Against Lung Cancer 2Health News:Abortion Does Not Increase Risk Of Depression In Women 2Health News:Passive Cigarette Smoking Increases Isoprostane Formation 2Health News:Want Strong Bones: Exercise And Eat Right! 2
Inquire...
Calss II Type B2 Biological Safety Cabinet...
External Calibration Only. Built-in RS232 Interface, Shimadzu WindowsDirect communication function. 120/240V A/C adapter....
... Semi-Micro balance. Built-in, motor-driven internal ... Performs Fully Automatic Self-Calibration when temperature ... intervals. Menu-selected weighing parameters, plug-in ... function keypads make this balance series ...
Medicine Products: